{"entity":{"id":"nct06463340","kind":"trial","name":"Study of SGR-3515 In Participants With Advanced Solid Tumors.","aka":[],"tldr":"A phase 1 trial of SGR-3515 run by Schrödinger, Inc., now recruiting.","summary":"Study of SGR-3515 In Participants With Advanced Solid Tumors. is a phase 1 interventional study registered as NCT06463340 by Schrödinger, Inc., with 52 participants planned, started 2024-06-18. Conditions recorded: Advanced Solid Tumor. Interventions recorded: SGR-3515.","status":"recruiting","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT06463340","url":"https://clinicaltrials.gov/study/NCT06463340"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["sgr-3515"],"companies":["schrodinger"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06463340","phase":"1","setting":"A First-In-Human, Phase 1, Dose Escalation Study of SGR-3515 In Participants With Advanced Solid Tumors.","sponsor":"Schrödinger, Inc.","enrolled":52,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06463340/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"drug":[{"id":"sgr-3515","kind":"drug","name":"SGR-3515","route":"/drugs/sgr-3515/"}],"company":[{"id":"schrodinger","kind":"company","name":"Schrödinger","route":"/companies/schrodinger/"}]}}